MRNA ▲ +8.6% - Moderna, Inc. $MRNA - Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 Moderna's stock climbed 8.6% following the company's announcement that it will present late-breaking data at the ESMO Congress 2026, a major European oncology conference. The disclosure of new clinical trial results at a top-tier medical meeting often signals positive developments in a company's pipeline and can boost investor confidence in its product candidates. 21-SEP-2026 10:12 AM ET